Cardiac Interventional Procedures in Cardio-Oncology Patients
Overview
Authors
Affiliations
Comorbidities specific to the cardio-oncology population contribute to the challenges in the interventional management of patients with cancer and cardiovascular disease (CVD). Patients with cancer have generally been excluded from cardiovascular randomized clinical trials. Endovascular procedures may represent a valid option in patients with cancer with a range of CVDs because of their minimally invasive nature. Patients with cancer are less likely to be treated according to societal guidelines because of perceived high risk. This article presents the specific challenges that interventional cardiologists face when caring for patients with cancer and the modern tools to optimize care.
Balanescu D, Bloomingdale R, Donisan T, Yang E, Parwani P, Iliescu C Rev Cardiovasc Med. 2024; 23(7):227.
PMID: 39076910 PMC: 11266791. DOI: 10.31083/j.rcm2307227.
Coronary Revascularization in Patients With Cancer.
Pushparaji B, Donisan T, Balanescu D, Park J, Monlezun D, Ali A Curr Treat Options Cardiovasc Med. 2023; 25(6):143-158.
PMID: 37143711 PMC: 10119009. DOI: 10.1007/s11936-023-00982-9.
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
Donisan T, Madanat L, Balanescu D, Mertens A, Dixon S Curr Cardiol Rev. 2023; 19(3):e030123212355.
PMID: 36597603 PMC: 10280993. DOI: 10.2174/1573403X19666230103154638.
Zhang M, Zhang H, Wu Q, Xue H, Fan L BMC Surg. 2022; 22(1):359.
PMID: 36229802 PMC: 9563462. DOI: 10.1186/s12893-022-01805-7.
Long A, Marik P J Investig Med High Impact Case Rep. 2020; 8:2324709620923237.
PMID: 32434415 PMC: 7243387. DOI: 10.1177/2324709620923237.